<DOC>
	<DOCNO>NCT02284464</DOCNO>
	<brief_summary>Steroids one pillars immunosuppression kidney transplant patient use associate high rate complication . Withdrawal steroid reduce metabolic cardiovascular complication , may increase risk acute rejection . However , little known whether steroid withdrawal associate generation anti-HLA donor-specific antibody ( DSA ) relation DSA clinical histological data . The aim study compare incidence de novo anti-HLA DSA stable kidney transplant patient withdraw steroid 3 month transplantation compare patient continue steroid . The hypothesis steroid withdrawal increase presence de novo anti-HLA DSA stable kidney transplant patient</brief_summary>
	<brief_title>Steroid Withdrawal Donor-specific Anti-HLA Antibodies Renal Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>1 . Male female patient age 18 year immunological risk ( PRA &lt; 25 % DSA ) receive first cadaveric living kidney transplant . 2 . Patients , three month transplantation , receive tacrolimus combination mycophenolic acid ( MPA ) mycophenolate mofetil ( MMF ) plus steroid , stable plasma level tacrolimus . 3 . No clinical histological immunological dysfunction randomization 4 . No de novo antiHLA DSA time randomization . 5 . Patients wish able give write informed consent participate study . 6 . For woman , agree use efficient contraception study . 1 . Patients receive multiorgan transplant . 2 . Retransplants . 3 . Presence DSA transplant time randomization . 4 . Cold ischemia time &gt; 30 hour 5 . Patients serum creatinine &gt; 2 mg/dL proteinuria &gt; 1g/day time randomization 6 . Prior episode severe rejection ( IIBIII Banff/13 classification ) prior randomization . 7 . Presence subclinical rejection borderline lesion protocol biopsy prior randomization 8 . Patients BKpolyomavirus nephropathy time randomization . 9 . Patients recurrent de novo glomerulonephritis . 10 . Patients treat immunosuppressive drug randomize clinical trial question . 11 . Patients positive human immunodeficiency virus ( HIV ) severe systemic infection , investigator 's judgment , require continued treatment . 12 . Patients present prior ( previous 5 year ) malignant disease , except basal squamous cell carcinoma excise .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Kidney transplant</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Steroid withdrawal</keyword>
	<keyword>Donor specific antibody</keyword>
</DOC>